News
The proof of concept trial will include both Lunit's AI solutions for chest x-ray and mammography analyses.
A Cerebral spokesperson said the cuts were "focused specifically on realizing operational efficiencies while prioritizing clinical quality and safety across the organization."
The company will speed up its clinical trial recruitment measures, raise awareness of post-approval treatments and support cancer research.
Aidoc will integrate Us2.ai's algorithm for analyzing echocardiograms into its proprietary operating system.
The acquisition will expand Unified's portfolio of women-focused companies to include menopause-relief offerings in all 50 states.
During a discussion at the Frontiers Health Global Hybrid Conference, panelists said a more competitive funding environment could push startups and investors to focus on quality.
When determining approval for Breakthrough Device designation, the FDA will consider whether the device addresses present health inequities.
Also, Royal Philips has expanded the roll-out of its AR surgical navigation solution to Japan.
The neurostimulation device, which is currently for investigational use only, aims to treat cognitive and functional decline in Alzheimer's patients.
The traditional healthcare industry could face pressure from changing trends, including the emergence of Amazon, Walmart, CVS and Walgreens as larger players.